Moderna, the first US company to begin Phase 3 clinical trials of a coronavirus vaccine in the US, increased its enrollment of minorities this week, but is still not even close to the levels requested by Dr. Anthony Fauci, director of the National Institute of Allergy ...
from Google Alert - health https://ift.tt/31HfPTn
via IFTTT
0 comments:
Post a Comment